Expert Interview
A Second Discussion: Understanding the impact of Eylea biosimilars on the wet-AMD market
Ticker(s): REGN, RHHBY, AMGNInstitution: University of Minnesota
- Vitreoreitnal surgeon and Associate Professor of Ophthalmology at University of Minnesota
- Manages over 100+ patients with wet-AMD
- Research Interest and Peer reviewed publications in imaging technology for vitreoretinal care and Macular degeneration.
Roughly how many patients do you manage with wet amd?
Added By: ben_adminHow many are on Eylea? Eylea HD?
Added By: ben_adminHow impactful has the approval of Eylea HD been on the treatment of your patients?
Added By: ben_adminHave you prescribed an Eylea biosimilar? If not why?
Does an Eylea biosimilar from a large company like Amgen make it more appealing?
Added By: ben_adminI would be interested in the practice economics and how they change over time vs eylea 2mg erosion over time. Also vabysmo vs hd eylea this year.
Added By: joe_mccannAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
